TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Labiro Medical AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
77
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
22
|
-1
|
-1 |
| EBITDA |
22
|
-1
|
-1 |
| Total assets |
40
|
10
|
29 |
| Current assets |
40
|
10
|
29 |
| Current liabilities |
17
|
1
|
1 |
| Equity capital |
23
|
9
|
28 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
1
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
57.5%
|
90.0%
|
96.6% |
| Turnover per employee | 77 | ||
| Profit as a percentage of turnover | 28.6% | ||
| Return on assets (ROA) |
55.0%
|
-10.0%
|
-3.4% |
| Current ratio |
235.3%
|
1000%
|
2900% |
| Return on equity (ROE) |
95.7%
|
-11.1%
|
-3.6% |
| Change turnover |
77
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.